Home / Products / Cancer (Tumor) Cell Lines / OVCA429
OVCA429
Datasheet Protocol

OVCA429

Cat. No. ARC0699
Product Type:

Cancer (Tumor) Cell Lines

Species:

Homo sapiens (Human)

Tissue Source:

Ovary

Growth Properties:

Adherent

In stock
$1,500.00 / Vial
Ask a Question

Short Description 🔒

OVCA429 is a cancer cell line of ovary cystadenocarcinoma, isolated from in situ; ovary.

Recommended Products

NFKB1 Knockout NCI-H1975 Polyclonal Cells NFKB1 Knockout NCI-H1975 Polyclonal Cells Cat. No. ARG17098 NCEH1 Knockout Hela Polyclonal Cells NCEH1 Knockout Hela Polyclonal Cells Cat. No. ARG8374 ISG15 Knockout CaSki Polyclonal Cells ISG15 Knockout CaSki Polyclonal Cells Cat. No. ARG35488 CCDC71L Knockout HGC-27 Polyclonal Cells CCDC71L Knockout HGC-27 Polyclonal Cells Cat. No. ARG43054 MOSPD1 Knockout MES-OV Polyclonal Cells MOSPD1 Knockout MES-OV Polyclonal Cells Cat. No. ARG6686 Human Ovarian Microvascular Endothelial Cell Medium Human Ovarian Microvascular Endothelial Cell Medium Cat. No. ARM0007
Product Details
Cell Engineering
Immortalization
Culture Conditions
Quality Control
Disclaimer

Product Details

Product Type:
Cancer (Tumor) Cell Lines
Species:
Homo sapiens (Human)
Tissue Source:
Ovary
Disease:
Cystadenocarcinoma
Morphology:
Epithelial-like
Growth Mode:
Adherent
Age:
Unknown
Sex of Donor:
Female
Derived From Site:
In situ; Ovary
Size/Quantity:
1 million
Shipping info:
Cryopreserved in vials and shipped on dry ice

Cell Engineering Information

No cell engineering information available.

Immortalization Information

No immortalization information available.

Culture Conditions

Temperature:
37°C
Atmosphere:
5% CO₂

Quality Control

Mycoplasma testing:
Negative for mycoplasma through PCR analysis
Sterility testing:
Daily monitoring confirms that the cells are free from bacterial, yeast, and fungal contamination.
Pathogens:
Cells tested negative for HIV-1, HBV, and HCV.

Disclaimer

Intended Use:
This product is intended for laboratory in vitro use only. It is not intended for diagnostic, therapeutic, or clinical applications.
Disclaimer:
Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability.
Usage:
By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use. This product is provided "AS IS".

Description 🔒

Complete description is available upon request.

Related Products You May Also Like

OTUD7B Knockout HT29 Polyclonal Cells

OTUD7B Knockout HT29 Polyclonal Cells

Cat. No. ARG13833
 LACTB2 Knockout HGC-27 Polyclonal Cells

LACTB2 Knockout HGC-27 Polyclonal Cells

Cat. No. ARG30154
 ITPK1 Knockout HGC-27 Polyclonal Cells

ITPK1 Knockout HGC-27 Polyclonal Cells

Cat. No. ARG30072
 BATF3 Knockout KYSE30 Polyclonal Cells

BATF3 Knockout KYSE30 Polyclonal Cells

Cat. No. ARG36289
 IFI27 Knockout UMUC-3 Polyclonal Cells

IFI27 Knockout UMUC-3 Polyclonal Cells

Cat. No. ARG36933
 ECI2 Knockout HT29 Polyclonal Cells

ECI2 Knockout HT29 Polyclonal Cells

Cat. No. ARG40410